Skip to main content

Advertisement

ADVERTISEMENT

Page not found. Search below.
Wound Care

A meta-analysis of 8 studies evaluated the effectiveness of hydrocolloid dressings in both preventing non-invasive ventilation (NIV) related facial PIs and enhancing wound healing in maxillofacial surgery. Outcome shows a significant reduction in facial PIs for NIV patients. IWJ

Wound Care

At a recent conference in Miami, SmartTRAK learned Urgo Medical US initiated the launch of UrgoClean Ag to the US market. The product is currently sold in Europe as a debridement product for the continual removal of slough.

Wound Care

A retrospective study showed a significant reduction in wound volume after a single DHAM (Dermacyte Matrix) application and a 50% reduction in size after approximately 2 DHAM applications for the treatment of DFUs and VLUs. JWC

Wound Care

Analysis of Medicare data in which skin substitutes/CTPs were used to treat hard-to-heal wounds found that the first application of a skin substitute product did not occur until 69 days after the initial treatment.

Wound Care

Aurealis Therapeutics announced completion of 50% of patient recruitment for its DIAMEND AUP-16 Phase II clinical trial for treatment of non-healing DFUs. These 30 patients are expected to complete the 12-week treatment in May 2024.

Journal of Clinical Pathways
Ranjit Manchada, PhD, and colleagues analyzed the cost-effectiveness of prevention strategies for ovarian cancer and breast cancer risk reduction for individuals who carry cancer susceptibility genes.
Wound Care

Spectral AI announced a new contract with the Defense Health Agency and the US Army Medical Material Development Activity that provides additional support for the development of the handheld version of DeepView Wound Imaging System. The contract is valued at over $0.5MM.

Wound Care

Swift Medical has announced a strategic co-investment from DIGITAL, Canada’s Global Innovation Cluster for digital technologies. The total project investment stands at $9.0MM, and is focused on using AI to forge significant advancements in patient outcomes and treatment equity.

Wound Care

Integra announced the launch of MicroMatrix Flex, a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix paste, to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.

Wound Care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
Vascular Disease Management
Watch as Dr. Timothy Yates reviews his ISET 2024 presentation on the current data available for the use of a 35 nm laser in below-the-knee arteries.
Journal of Clinical Pathways
A recent study examined the effects of an individualized starting dose of niraparib on hematologic adverse events in patients with advanced ovarian cancer.
Psych Congress Network
This video, featuring Roger McIntyre, MD, FRCPC, highlights anxiety and anhedonia symptoms as possible residual symptoms that may be experienced by adult MDD patients with inadequate response to antidepressant therapy.
Vascular Disease Management
In this video, Dr. Eric Secemsky talks about his ISET 2024 presentation on setting up a renal denervation program.
Cath Lab Digest
Importantly, this approach tackles the underlying cellular dysfunctions caused by diabetes, providing a highly effective strategy for enhancing wound repair. This research opens new pathways for developing advanced treatments for diabetic patients, potentially transforming the management of diabetic wounds and reducing the need for drastic measures like amputations.
Neurology Learning Network
Exposure to high temperatures was associated with an increased risk of acute ischemic stroke (AIS) onset at an hourly level, according to results from national case-crossover study in China published in JAMA Network Open.
Oncology
The novel myeloma CAR T Relapse prognostic model may be useful in strategizing optimal timing of CAR T-cell therapy in certain subgroups of patients with R/R MM, according to an international, retrospective study.
Oncology
First-line therapy with immune checkpoint inhibition plus chemotherapy did not significantly improve overall survival or progression-free survival compared to immune checkpoint inhibition alone among older patients with advanced non-small cell lung cancer.
Pharmacy Learning Network
Patients are gaining back the weight they lost after discontinuing Ozempic. Experts do not recommend lifelong Ozempic use, and side effects highlighting discontinuation for patients struggling with weight loss.
Psych Congress Network
Through this short video, you’ll learn more about akathisia and tardive dyskinesia as being possible movement disorder side effects related to the adjunctive use of atypical antipsychotics in adult patients with major depressive disorder (MDD).

Advertisement